Nothing Special   »   [go: up one dir, main page]

Schmid et al., 1970 - Google Patents

COMPLEMENT FIXATION BY A TWO-COMPONENT ANTIBODY SYSTEM: IMMUNOGLOBULIN G AND IMMUNOGLOBULIN M ANTI-GLOBULIN (RHEUMATOID …

Schmid et al., 1970

View PDF
Document ID
281645050411315324
Author
Schmid F
Roitt I
Rocha M
Publication year
Publication venue
The Journal of Experimental Medicine

External Links

Snippet

Complement-mediated lysis of sheep erythrocytes coated with optimal concentrations of rabbit IgG hemolysin was inhibited by euglobulin fractions from the sera of patients with seropositive rheumatoid arthritis. That this was due to direct interaction with the IgG coat on …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Similar Documents

Publication Publication Date Title
Schmid et al. COMPLEMENT FIXATION BY A TWO-COMPONENT ANTIBODY SYSTEM: IMMUNOGLOBULIN G AND IMMUNOGLOBULIN M ANTI-GLOBULIN (RHEUMATOID FACTOR) Paradoxical Effect Related to Immunoglobulin G Concentration
Huber et al. Receptor sites of human monocytes for IgG
Mortensen et al. Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors
Abramson et al. The interaction between human monocytes and red cells: specificity for IgG subclasses and IgG fragments
Theofilopoulos et al. Immune complexes in human diseases: a review.
Butler et al. Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies
Sokol et al. Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre.
Luiken et al. Platelet-associated IgG in immune thrombocytopenic purpura
Israels et al. Platelet Fc receptor as a mechanism for Ag-Ab complex-induced platelet injury
Matre et al. Complement receptors in human renal glomeruli
SINGER et al. The presence of anti-gamma globulin factors in sera of patients with active pulmonary tuberculosis
Mannik et al. IgG rheumatoid factors and self-association of these antibodies
Fröland et al. Lymphocytes with membrane-bound immunoglobulin (B-lymphocytes) in new-born babies
Kishimoto et al. Regulation of antibody response in vitro: IV. Heavy chain antigenic determinants on hapten-specific memory cells
Kline et al. Three sera defining a new granulocyte-monocyte-T-lymphocyte antigen
Tesar et al. Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor
Williams et al. Studies of human sera with cytotoxic activity
Hsu et al. Instrumented PVP-augmented antiglobulin tests
Spiegelberg et al. Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes
LIGHTSEY et al. Immune neutropenia
Fleer et al. Destruction of IgG‐sensitized erythrocytes by human blood monocytes: modulation of inhibition by IgG
Cines et al. Granulocyte-associated IgG in neutropenic disorders
Sjöberg Presence of receptors for IgD on human T and non‐T lymphocytes
McCallister et al. The use and limitation of labeled staphylococcal protein A for study of antineutrophil antibodies
Thompson et al. IgE Fc receptor positive T and B lymphocytes in patients with the hyper IgE syndrome.